Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Srdan Tadic
Institution:
Center for Biomedical Research of La Rioja
Observed institution:
Center for Biomedical Research of La Rioja
ORCID:
0000-0001-8670-0427
Observed ORCID:
0000-0001-8670-0427
OpenAlex ID:
A5047683785
Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?
2024
·
Srdan Tadic
, Alfredo Martínez
·
Frontiers in Immunology
·
23
Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
2023
·
Iris A. Bermejo
, Ana Guerreiro
, et al.
·
JACS Au
·
21
An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model
2025
·
Srdan Tadic
, Laura Ochoa-Callejero
, et al.
·
Frontiers in Immunology
·
9
PDF
A DNA Vaccine Against Proadrenomedullin N-Terminal 20 Peptide (PAMP) Reduces Angiogenesis and Increases Lymphocyte and Macrophage Infiltration but Has No Effect on Tumor Burden in a Mouse Model of Lung Metastasis
2025
·
Tom Kalathil Raju
, Srdan Tadic
, et al.
·
Vaccines
·
3
PDF
A Stable RNA Vaccine Against the Regulatory Peptide Adrenomedullin Reduces Angiogenesis and Tumor Burden in a Subcutaneous Melanoma Model Without Inducing an Immunosuppressive Tumor Microenvironment
2025
·
Srdan Tadic
, Josune García-Sanmartín
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Anti-VEGF immunotherapy with HEBERSaVax suppresses melanoma growth and metastasis via angiogenesis blockade and enhanced T-cell infiltration
2025
·
Yanelys Morera-Díaz
, Josune García-Sanmartín
, et al.
·
Frontiers in Immunology
·
1
PDF
Abstract 4783: An mRNA vaccine targeting angiogenesis elicits a robust immune response and inhibits tumor growth and angiogenesis in two mouse melanoma models
2026
·
Srdan Tadic
, Laura Ochoa-Callejero
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
59
H-index:
3
I10-index:
2
Year
Topic
Type